Iron deficiency in cardiac surgery patients and the possibility of its correction at the preoperative stage

Among cardio-surgical patients, the prevalence of iron deficiency conditions reaches 70 %, and anemia is detected in less than 50% cases. Meanwhile, both anemia and latent iron deficiency are risk factors for adverse outcomes in cardio-surgical patients. These conditions are associated with a high frequency and greater volume of blood transfusions as well as with a longer stay in the hospital. Timely diagnosis and correction of iron deficiency, regardless of the presence of anemia, are mandatory at the stage of preoperative preparation. The use of oral iron medicines is limited by their low efficacy in this category of patients and a high risk of adverse events. Intravenous iron medicines have a high potential for correcting iron deficiency, and their efficacy and safety have been previously demonstrated. Administration of ferric carboxymaltose has proved beneficial in studies on iron deficiency correction in cardiological and cardio-surgical patients. In these patients, ferric carboxymaltose improved the dynamics of ferritin and hemoglobin, reduced the risk of blood transfusion, and decreased the duration of stay in the hospital. Preoperative intravenous administration of ferric carboxymaltose to cardio-surgical patients can improve clinical outcomes and the cost effectiveness of cardiac surgery.

1. World Health Organization. Worldwide prevalence of anaemia 1993- 2005: WHO global database on anaemia. Edited by B. de Benoist, E. McLean, I. Egli and M. Cogswell. - Geneva: WHO; 2008. - 40p. ISBN 978-92-4-159665-7

2. Safiri S, Kolahi A-A, Noori M, Nejadghaderi SA, Karamzad N, Bragazzi NL et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. Journal of Hematology & Oncology. 2021;14(1):185. DOI: 10.1186/s13045-021-01202-2

3. Mareev V.Yu., Begrambekova Yu.L., Mareev Yu.V., Kobalava Zh.D., Karapetyan L.V., Galochkin S.A. et al. Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study. Kardiologiia. 2022;62(5):4–8. DOI: 10.18087/cardio.2022.5.n2083

4. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107(2):223–5. DOI: 10.1161/01.CIR.0000052622.51963.FC

5. Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D. Iron Deficiency: A New Target for Patients With Heart Failure. Frontiers in Cardiovascular Medicine. 2021;8:709872. DOI: 10.3389/fcvm.2021.709872

6. Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80– 98. DOI: 10.1161/CIRCULATIONAHA.118.030099

7. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG et al. Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology. 2006;48(12):2485–9. DOI: 10.1016/j.jacc.2006.08.034

8. Hubert M, Gaudriot B, Biedermann S, Gouezec H, Sylvestre E, Bouzille G et al. Impact of Preoperative Iron Deficiency on Blood Transfusion in Elective Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(8):2141–50. DOI: 10.1053/j.jvca.2019.02.006

9. Immohr MB, Sugimura Y, Aubin H, Rellecke P, Boeken U, Lichtenberg A et al. Iron deficiency does not impair the outcome after elective coronary artery bypass and aortic valve procedures. Journal of Cardiac Surgery. 2021;36(2):542–50. DOI: 10.1111/jocs.15254

10. Piednoir P, Allou N, Driss F, Longrois D, Philip I, Beaumont C et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. European Journal of Anaesthesiology. 2011;28(11):796–801. DOI: 10.1097/EJA.0b013e32834ad97b

11. Miles LF, Story DA. Blood and iron: associations with poor outcome after cardiac surgery. British Journal of Anaesthesia. 2020;124(1):1–3. DOI: 10.1016/j.bja.2019.09.019

12. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. Journal of the American College of Cardiology. 2000;35(7):1737–44. DOI: 10.1016/S0735-1097(00)00613-6

13. Polyakova O.A., Klepikova M.V., Litvinova S.N., Isaakyan Yu.A., Ostroumova O.D. Iron deficiency and iron deficiency anemia in general medical practice. Preventive Medicine. 2022;25(12):127–34DOI: 10.17116/profmed202225121127

14. Ministry of Health of Russian Federation. Clinical Recomendation - Iron deficiency anemia – 2021- 2022-2023 (09.09.2021). Av. at: disuria.ru/_ld/10/1070_kr21D50MZ.pdf.

15. Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S et al. Iron status in patients with chronic heart failure. European Heart Journal. 2013;34(11):827–34. DOI: 10.1093/eurheartj/ehs377

16. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958–66. DOI: 10.1001/jama.2017.5427

17. McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? European Journal of Heart Failure. 2015;17(3):248–62. DOI: 10.1002/ejhf.236

18. Von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron Deficiency in Heart Failure: An Overview. JACC: Heart Failure. 2019;7(1):36–46. DOI: 10.1016/j.jchf.2018.07.015

19. Nakazone MA, Machado MN, Otaviano AP, Rodrigues AMS, Cardinalli-Neto A, Bestetti RB. Prognostic Significance of Chronic Kidney Disease (CKD-EPI Equation) and Anemia in Patients with Chronic Heart Failure Secondary to Chagas Cardiomyopathy. Cardiology Research and Practice. 2020;2020:1–7. DOI: 10.1155/2020/6417874

20. Salvatore T, Galiero R, Caturano A, Rinaldi L, Di Martino A, Albanese G et al. An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors. International Journal of Molecular Sciences. 2022;23(7):3651. DOI: 10.3390/ijms23073651

21. Kopylov F.Yu., Shchekochikhin D.Yu. Anemia in chronic heart failure. Russian Medical Journal. 2011;19(7):440–3.

22. Karkouti K, Wijeysundera DN, Beattie WS. Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study. Circulation. 2008;117(4):478–84. DOI: 10.1161/CIRCULATIONAHA.107.718353

23. Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. British Journal of Surgery. 2015;102(11):1314–24. DOI: 10.1002/bjs.9861

24. Klein AA, Collier TJ, Brar MS, Evans C, Hallward G, Fletcher SN et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK - the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia. 2016;71(6):627–35. DOI: 10.1111/anae.13423

25. Golukhova E.Z., Kupryashov A.A., Khicheva G.A., Kuksina E.V., Volkova O.I., Kurilovich E.O. et al. Socio-economic assessment of patient blood management practical implementation in surgical treatment of coronary heart disease (I20–I25). Kardiologiia. 2021;61(3):77–86. DOI: 10.18087/cardio.2021.3.n1557

26. Venturini E, Iannuzzo G, Di Lorenzo A, Cuomo G, D’Angelo A, Merone P et al. Short-term treatment of iron deficiency anemia after cardiac surgery. IJC Heart & Vasculature. 2022;40:101038. DOI: 10.1016/j.ijcha.2022.101038

27. Padmanabhan H, Siau K, Nevill AM, Morgan I, Cotton J, Ng A et al. Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial. Interactive CardioVascular and Thoracic Surgery. 2019;28(3):447–54. DOI: 10.1093/icvts/ivy226

28. Karkouti K, Yip P, Chan C, Chawla L, Rao V. Pre-operative anaemia, intra-operative hepcidin concentration and acute kidney injury after cardiac surgery: a retrospective observational study. Anaesthesia. 2018;73(9):1097–102. DOI: 10.1111/anae.14274

29. Rössler J, Schoenrath F, Seifert B, Kaserer A, Spahn GH, Falk V et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. British Journal of Anaesthesia. 2020;124(1):25–34. DOI: 10.1016/j.bja.2019.09.016

30. Zafrir B, Leviner DB, Saliba W, Sharoni E. Prognostic Interplay of Chronic Kidney Disease, Anemia, and Diabetes in Coronary Bypass Surgery. The Annals of Thoracic Surgery. 2021;111(1):94–101. DOI: 10.1016/j.athoracsur.2020.04.124

31. Tramarin R, Pistuddi V, Maresca L, Pavesi M, Castelvecchio S, Menicanti L et al. Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery. European Journal of Preventive Cardiology. 2017;24(8):799–807. DOI: 10.1177/2047487317689975

32. Hare GMT, Mazer CD. Anemia: Perioperative Risk and Treatment Opportunity. Anesthesiology. 2021;135(3):520–30. DOI: 10.1097/ALN.0000000000003870

33. Bhattacharya PT, Misra SR, Hussain M. Nutritional Aspects of Essential Trace Elements in Oral Health and Disease: An Extensive Review. Scientifica. 2016;2016:1–12. DOI: 10.1155/2016/5464373

34. Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function: Impaired contractility in iron-deficient cardiomyocytes. European Journal of Heart Failure. 2018;20(5):910–9. DOI: 10.1002/ejhf.1154

35. Stugiewicz M, Tkaczyszyn M, Kasztura M, Banasiak W, Ponikowski P, Jankowska EA. The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications: Iron deficiency and skeletal muscles. European Journal of Heart Failure. 2016;18(7):762–73. DOI: 10.1002/ejhf.467

36. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery. Circulation. 2007;116(22):2544–52. DOI: 10.1161/CIRCULATIONAHA.107.698977

37. Garrido-Martin P, Nassar-Mansur MI, De La Llana-Ducros R, VirgosAller TM, Fortunez PMR, Avalos-Pinto R et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interactive CardioVascular and Thoracic Surgery. 2012;15(6):1013–8. DOI: 10.1093/icvts/ivs344

38. Chau M, Richards T, Evans C, Butcher A, Collier T, Klein A. The UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study: protocol for an observational cohort study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients. BMJ Open. 2017;7(4):e014872. DOI: 10.1136/bmjopen-2016-014872

39. Jabagi H, Boodhwani M, Tran DT, Sun L, Wells G, Rubens FD. The Effect of Preoperative Anemia on Patients Undergoing Cardiac Surgery: A Propensity-Matched Analysis. Seminars in Thoracic and Cardiovascular Surgery. 2019;31(2):157–63. DOI: 10.1053/j.semtcvs.2018.09.015

40. Muñoz M, Acheson AG, Bisbe E, Butcher A, Gómez‐Ramírez S, Khalafallah AA et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia. 2018;73(11):1418–31. DOI: 10.1111/anae.14358

41. Muñoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233– 47. DOI: 10.1111/anae.13773

42. Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. The Lancet. 2019;393(10187):2201–12. DOI: 10.1016/S0140-6736(18)32555-8

43. Meybohm P, Westphal S, Ravn HB, Ranucci M, Agarwal S, Choorapoikayil S et al. Perioperative Anemia Management as Part of PBM in Cardiac Surgery – A Narrative Updated Review. Journal of Cardiothoracic and Vascular Anesthesia. 2020;34(4):1060–73. DOI: 10.1053/j. jvca.2019.06.047

44. Kloeser R, Buser A, Bolliger D. Treatment Strategies in Anemic Patients Before Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(2):266–75. DOI: 10.1053/j.jvca.2022.09.085

45. Ambrosy AP, Lewis GD, Malhotra R, Jones AD, Greene SJ, Fudim M et al. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. Journal of Cardiovascular Medicine. 2019;20(4):223–5. DOI: 10.2459/JCM.0000000000000736

46. Ministry of Health of Russian Federation. Clinical Recommendation. Chronic heart failure. Av. at: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_HSN-unlocked.pdf. 2020.

47. Ng O, Keeler BD, Mishra A, Simpson JA, Neal K, Al-Hassi HO et al. Iron therapy for preoperative anaemia. Cochrane Database of Systematic Reviews. 2019;12(12):CD011588. DOI: 10.1002/14651858.CD011588.pub3

48. Kong R, Hutchinson N, Hill A, Ingoldby F, Skipper N, Jones C et al. Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). British Journal of Anaesthesia. 2022;128(5):796–805. DOI: 10.1016/j.bja.2022.01.034

49. Klein AA, Chau M, Yeates JA, Collier T, Evans C, Agarwal S et al. Preoperative intravenous iron before cardiac surgery: a prospective multicentre feasibility study. British Journal of Anaesthesia. 2020;124(3):243–50. DOI: 10.1016/j.bja.2019.11.023

50. Peel JK, Trudeau J, Tano R, Jadunandan S, Callum J, Moussa F et al. Determining Optimal Treatment to Correct Preoperative Anemia and Reduce Perioperative Allogeneic Blood Transfusions in Cardiac Surgery: A Retrospective Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(9):2631–9. DOI: 10.1053/j.jvca.2020.12.044

51. Xu H, Duan Y, Yuan X, Wu H, Sun H, Ji H. Intravenous Iron Versus Placebo in the Management of Postoperative Functional Iron Deficiency Anemia in Patients Undergoing Cardiac Valvular Surgery: A Prospective, Single-Blinded, Randomized Controlled Trial. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(11):2941–8. DOI: 10.1053/j.jvca.2019.01.063

52. Chau M. An observational study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients: The UK CAVIAR Study. [DOI: 10.1186/ISRCTN55032357]

53. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al. Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. European Journal of Heart Failure. 2009;11(11):1084–91. DOI: 10.1093/eurjhf/hfp140

54. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal. 2015;36(11):657– 68. DOI: 10.1093/eurheartj/ehu385

55. Anker SD, Kirwan B-A, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis: Outcomes in iron-deficient heart failure patients. European Journal of Heart Failure. 2018;20(1):125– 33. DOI: 10.1002/ejhf.823

56. Corsi F, Pasquini A, Guerrera M, Bevilacqua F, Taccheri T, Antoniucci ME et al. Single shot of intravenous iron in cardiac surgery: The ICARUS study. Journal of Clinical Anesthesia. 2023;84:111009. DOI: 10.1016/j.jclinane.2022.111009

57. Houry M, Tohme J, Sleilaty G, Jabbour K, Bou Gebrael W, Jebara V et al. Effects of ferric carboxymaltose on hemoglobin level after cardiac surgery: A randomized controlled trial. Anaesthesia Critical Care & Pain Medicine. 2023;42(1):101171. DOI: 10.1016/j.accpm.2022.101171

58. Nugara C, Vitale G, Caccamo G, Sarullo S, Giallauria F, Di Franco A et al. Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery. Monaldi Archives for Chest Disease. 2020;90(1):33–7. DOI: 10.4081/monaldi.2020.1196

59. Peters F, Eveslage M, Gallitz I, Wempe C, Meybohm P, Van Aken HK et al. Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron. Transfusion Medicine and Hemotherapy. 2018;45(1):42–6. DOI: 10.1159/000481143